Medicine & Life Sciences
Acute Myeloid Leukemia
100%
plerixafor octahydrochloride
67%
Graft vs Host Disease
65%
Granulocyte Colony-Stimulating Factor
59%
Transplants
59%
Cell Transplantation
56%
Hematopoietic Stem Cell Mobilization
53%
Hematopoietic Stem Cells
49%
Multiple Myeloma
48%
Allogeneic Cells
48%
Stem Cell Transplantation
47%
Stem Cells
43%
Bone Marrow
42%
T-Lymphocytes
37%
Neoplasms
37%
Leukemia
35%
Tissue Donors
35%
Mutation
31%
Myelodysplastic Syndromes
31%
Hematopoietic Stem Cell Transplantation
31%
Peripheral Blood Stem Cells
30%
Therapeutics
29%
Survival
28%
Transplantation
28%
Granulocyte-Macrophage Colony-Stimulating Factor
26%
Non-Hodgkin's Lymphoma
26%
Homologous Transplantation
25%
Autologous Transplantation
22%
Unrelated Donors
22%
Hematologic Neoplasms
22%
Drug Therapy
22%
GATA2 Deficiency
22%
INCB018424
21%
Bone Marrow Transplantation
21%
Genome
20%
Chimeric Antigen Receptors
20%
Recurrence
20%
Neutrophils
18%
Cyclophosphamide
18%
Peripheral Blood Stem Cell Transplantation
17%
Decitabine
17%
Cytarabine
16%
Atlases
16%
Immunotherapy
15%
Genes
15%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
14%
Whole-Body Irradiation
14%
Blood Cells
14%
Progression-Free Survival
14%
Placebos
13%